FDA initiative for diversity in cancer studies disappears : Shots
Key guidance to industry on enhancing diversity in clinical trials of cancer drugs disappeared from the Food and Drug Administration...
Key guidance to industry on enhancing diversity in clinical trials of cancer drugs disappeared from the Food and Drug Administration...
Springfield, Mo., Nov. 20, 2024 (GLOBE NEWSWIRE) -- In response to the persistently high nationwide burden of colorectal cancer (CRC),...
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USAW. T. Cefalu & N. A. ZaghloulDepartment...